[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334529-105":59,"doc-detail-334529-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","an-inflamed-tumor-cell-subpopulation-promotes-chemotherapy-resistance-in-triple-negative-breast-cancer","An inflamed tumor cell subpopulation promotes chemotherapy resistance in triple negative breast cancer","","Cancer comprises heterogeneous tumor cells with distinct phenotypes and genotypes, and triple negative breast cancer (TNBC) shows marked heterogeneity. Transcriptional variability among tumor cells can restrict monotherapy effectiveness and contribute to drug resistance, but the extent and mechanisms remain unclear. Using single-cell RNA-seq on breast cancer cell line and PDX models, the study identifies TNBC subpopulations linked to resistance to standard-of-care therapies. A TNBC inflamed cellular state features heightened cGAS/STING signaling, sufficient to drive chemotherapy resistance, and correlates with post-neoadjuvant enrichment, early recurrence, and clinical need.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/an-inflamed-tumor-cell-subpopulation-promotes-chemotherapy-resistance-in-triple-negative-breast-cancer/334529/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/an-inflamed-tumor-cell-subpopulation-promotes-chemotherapy-resistance-in-triple-negative-breast-cancer/334529.png","ImageObject",300,407,{"name":92,"@type":93},"Patrick","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-26","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does the study address about TNBC drug resistance?","Question",{"text":112,"@type":113},"It tests whether transcriptional differences between individual tumor cells lead to different drug responses, contributing to resistance in TNBC.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were resistant tumor cell subpopulations identified?",{"text":117,"@type":113},"The researchers performed single-cell RNA-seq on breast cancer cell line and patient-derived xenograft (PDX) models, then used statistical and computational modeling to link subpopulations with intrinsic resistance.",{"name":119,"@type":110,"acceptedAnswer":120},"What role do inflamed cells and cGAS/STING signaling play?",{"text":121,"@type":113},"Inflamed TNBC cells show evidence of heightened cGAS/STING signaling, and this signaling is demonstrated as sufficient to cause tumor cell resistance to chemotherapy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334529,1790490590,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nAn inflamed tumor cell subpopulation promotes chemotherapy resistance in triple negative breast cancer  \nMauricio Jacobo Jacobo1,4, Hayley J. Donnella1,4, Sushil Sobti1, Swati Kaushik1, Andrei Goga2,3 & Sourav Bandyopadhyay1*  \nIndividual cancers are composed of heterogeneous tumor cells with distinct phenotypes and genotypes, with triple negative breast cancers (TNBC) demonstrating the most heterogeneity among breast cancer types. Variability in transcriptional phenotypes could meaningfully limit the efficacy of monotherapies and fuel drug resistance, although to an unknown extent. To determine if transcriptional differences between tumor cells lead to differential drug responses we performed single cell RNA-seq on cell line and PDX models of breast cancer revealing cell subpopulations in states associated with resistance to standard-of-care therapies. We found that TNBC models contained a subpopulation in an inflamed cellular state, often also present in human breast cancer samples. Inflamed cells display evidence of heightened cGAS/STING signaling which we demonstrate is sufficient to cause tumor cell resistance to chemotherapy. Accordingly, inflamed cells were enriched in human tumors taken after neoadjuvant chemotherapy and associated with early recurrence, highlighting the potential for diverse tumor cell states to promote drug resistance.  \nIntratumoral heterogeneity (ITH) denotes the presence of cancer cell subpopulations that differ in their genetic, phenotypic or behavioral characteristics imparting the ability to overcome various selective pressures1,2. ITH can occur across and within disease sites leading to spatial and longitudinal variation3,4 which can promote various aspects of tumor progression and metastasis. ITH is associated with drug resistance and poor outcomes in breast and other cancers5,6. As the most aggressive disease subtype accounting for 12 to 18% of all cases and associated with the poorest of outcomes7,8, triple-negative breast cancers (TNBCs) display profound ITH9. ITH could result in the expansion of resistant cells with genetic or non-genetic differences3,4. While genetic differences between cancer cells have been shown to pre-exist10–12, much less is known about pre-existing non-genetic variability in cancer cells which could arise from stochastic fluctuations, variation in the tumor microenvironment and spatial localization13, 14. However, only certain types of non-genetic variability may be relevant to impact clinical outcomes such as drug resistance. Defining axes of variation in cell states and identifying those leading to altered drug responses and outcomes in cancer patients remains a challenge.  \nDrug resistance is a major concern in breast cancer complicating the treatment of both metastatic disease which is largely incurable and localized disease where there is a 40 to 80% risk of recurrence after neoadjuvant therapy15–17. Drug resistance is a ubiquitous problem impacting responses for both chemotherapy as well as targeted therapies. For example, HER2 inhibitor treatment leads to a pathologic complete response in only 25 to 30% of HER2 + breast cancers18, 19. It has been suggested that ITH is a potential significant factor impeding treatment of breast cancers20,21. Although ITH can lead to the Darwinian selection of pre-existing genetically diverse subclones9,22,23, clinical evidence from breast cancers undergoing neoadjuvant therapy have indicated treatment often does not result in subclonal selection demonstrating that it is not necessarily genetically encoded9,24–26. These data highlight the importance of understanding potential non-genetic mechanisms that contribute to drug resistance, which could illuminate new treatment approaches and regimes.  \n1Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA 94143, USA. 2Department of Cell & Tissue ","cbCaigF6mFJN9rzF","https://ap.wps.com/l/cbCaigF6mFJN9rzF","pdf",10349838,15,"English","# Results\n## Single-cell heterogeneity is pervasive across various models of breast cancer","[{\"question\":\"What question does the study address about TNBC drug resistance?\",\"answer\":\"It tests whether transcriptional differences between individual tumor cells lead to different drug responses, contributing to resistance in TNBC.\"},{\"question\":\"How were resistant tumor cell subpopulations identified?\",\"answer\":\"The researchers performed single-cell RNA-seq on breast cancer cell line and patient-derived xenograft (PDX) models, then used statistical and computational modeling to link subpopulations with intrinsic resistance.\"},{\"question\":\"What role do inflamed cells and cGAS/STING signaling play?\",\"answer\":\"Inflamed TNBC cells show evidence of heightened cGAS/STING signaling, and this signaling is demonstrated as sufficient to cause tumor cell resistance to chemotherapy.\"}]","An inflamed tumor cell subpopulation promotes chemotherapy resistance in triple negative breast cancer | PDF",1790007080,38]